Spencer J Anthony-Cahill is a notable inventor based in Bellingham, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of modified hemoglobin compounds. With a total of 4 patents to his name, his work has implications for various medical applications.

Latest Patents

One of his latest patents is titled "Globins containing binding domains." This invention relates to globins that include non-naturally occurring binding domains. Specifically, it focuses on a binding domain that comprises the oligomerizing domain GCN4 and its derivatives. Another significant patent is "Modified hemoglobin-like compounds and methods of purifying same," which addresses the purification of modified hemoglobin compounds for potential therapeutic uses.

Career Highlights

Throughout his career, Spencer has worked with several prominent companies, including Baxter Biotech Technology Sarl and Somatogen, Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in biotechnology.

Collaborations

Spencer has collaborated with notable individuals in his field, including Antony James Mathews and David C Anderson. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.

Conclusion

Spencer J Anthony-Cahill is a distinguished inventor whose work in hemoglobin research has led to valuable patents and advancements in biotechnology. His contributions continue to influence the field and pave the way for future innovations.